Literature DB >> 24395216

Ochratoxin A: developmental and reproductive toxicity-an overview.

Frantisek Malir1, Vladimir Ostry, Annie Pfohl-Leszkowicz, Eva Novotna.   

Abstract

Ochratoxin A (OTA) is nephrotoxic, hepatotoxic, reprotoxic, embryotoxic, teratogenic, neurotoxic, immunotoxic, and carcinogenic for laboratory and farm animals. Male and female reproductive health has deteriorated in many countries during the last few decades. A number of toxins in environment are suspected to affect reproductive system in male and female. OTA is one of them. OTA has been found to be teratogenic in several animal models including rat, mouse, hamster, quail, and chick, with reduced birth weight and craniofacial abnormalities being the most common signs. The presence of OTA also results in congenital defects in the fetus. Neither the potential of OTA to cause malformations in human nor its teratogenic mode of action is known. Exposure to OTA leads to increased embryo lethality manifested as resorptions or dead fetuses. The mechanism of OTA transfer across human placenta (e.g., which transporters are involved in the transfer mechanism) is not fully understood. Some of the toxic effects of OTA are potentiated by other mycotoxins or other contaminants. Therefore, OTA exposure of pregnant women should be minimized. OTA has been shown to be an endocrine disruptor and a reproductive toxicant, with abilities of altering sperm quality. Other studies have shown that OTA is a testicular toxin in animals. Thus, OTA is a biologically plausible cause of testicular cancer in man.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  developmental toxicity; ochratoxin A; pregnant woman; reprotoxicity; teratogenicity; testicular cancer

Mesh:

Substances:

Year:  2014        PMID: 24395216     DOI: 10.1002/bdrb.21091

Source DB:  PubMed          Journal:  Birth Defects Res B Dev Reprod Toxicol        ISSN: 1542-9733


  19 in total

1.  Mycotoxin ochratoxin A disrupts renal development via a miR-731/prolactin receptor axis in zebrafish.

Authors:  Ting-Shuan Wu; Jiann-Jou Yang; Yan-Wei Wang; Feng-Yih Yu; Biing-Hui Liu
Journal:  Toxicol Res (Camb)       Date:  2016-01-04       Impact factor: 3.524

2.  Assessment of serum aflatoxin B1 levels in neonatal jaundice with glucose-6-phosphate dehydrogenase deficiency: a preliminary study.

Authors:  Nermin Raafat; Wafaa A Emam; Amal F Gharib; Ola E Nafea; Marwa Zakaria
Journal:  Mycotoxin Res       Date:  2021-01-11       Impact factor: 3.833

3.  Biomonitoring of concurrent exposure to ochratoxin A and citrinin in pregnant women in Bangladesh.

Authors:  Nurshad Ali; Meinolf Blaszkewicz; M Manirujjaman; Gisela H Degen
Journal:  Mycotoxin Res       Date:  2016-05-17       Impact factor: 3.833

4.  Contribution of organ vasculature in rat renal analysis for ochratoxin a: relevance to toxicology of nephrotoxins.

Authors:  Peter Mantle; Mehmet A Kilic; Firdevs Mor; Ozlem Ozmen
Journal:  Toxins (Basel)       Date:  2015-03-24       Impact factor: 4.546

Review 5.  Recent Advances for the Detection of Ochratoxin A.

Authors:  Tai Hwan Ha
Journal:  Toxins (Basel)       Date:  2015-12-04       Impact factor: 4.546

Review 6.  Ochratoxin A: 50 Years of Research.

Authors:  Frantisek Malir; Vladimir Ostry; Annie Pfohl-Leszkowicz; Jan Malir; Jakub Toman
Journal:  Toxins (Basel)       Date:  2016-07-04       Impact factor: 4.546

7.  Evaluation of Ochratoxin Recognition by Peptides Using Explicit Solvent Molecular Dynamics.

Authors:  Aby A Thyparambil; Ingrid Bazin; Anthony Guiseppi-Elie
Journal:  Toxins (Basel)       Date:  2017-05-13       Impact factor: 4.546

Review 8.  Immunohistochemical Review of Leydig Cell Lesions in Ochratoxin A-Treated Fischer Rats and Controls.

Authors:  Diana Herman; Peter Mantle
Journal:  Toxins (Basel)       Date:  2019-08-20       Impact factor: 4.546

9.  Maternal-Fetal Cancer Risk Assessment of Ochratoxin A during Pregnancy.

Authors:  Chit Shing Jackson Woo; Hani El-Nezami
Journal:  Toxins (Basel)       Date:  2016-03-23       Impact factor: 4.546

10.  Protective effects of compound ammonium glycyrrhizin, L‑arginine, silymarin and glucurolactone against liver damage induced by ochratoxin A in primary chicken hepatocytes.

Authors:  Zugong Yu; Feng Wu; Jing Tian; Xuewen Guo; Ran An
Journal:  Mol Med Rep       Date:  2018-07-16       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.